Study boost for Roche’s Actemra
October 30, 2008Research and Development, Sales and Marketing RA, Roche
New data shows Roche's Actemra (tocilizumab) increases the disease remission rate in rheumatoid arthritis (RA) sufferers. The company says the …
Alzheimer’s companies hope renewed by House of Lords
October 30, 2008Sales and Marketing Alzheimer's, NICE
The companies behind Alzheimer's drug Aricept have won the right to see the economic model NICE used to assess the …
Strong results for Novartis drug in rare autoimmune disease
October 30, 2008Research and Development, Sales and Marketing Novartis
Novartis' development drug ACZ885 (canakinumab) has turned in impressive results in trials for rare medical conditions. It showed sustained remission …
GSK to acquire Hepatitis C specialists Genelabs
October 30, 2008Sales and Marketing GSK, Genelabs, MA
GlaxoSmithKline is to pay $57 million (£35 million) for Genelabs, California-based specialists in infectious diseases, including hepatitis C. The companies …
Specialising for success
October 29, 2008Research and Development, Sales and Marketing marketing, product portfolio
From the middle of the last century, the likes of GSK, Pfizer, AstraZeneca, Bristol Myers Squibb and others have made …
Working Life: Philip Sarbutt
October 28, 2008Research and Development, Sales and Marketing UK, Wyeth, Wyeth Pharmaceuticals, outsourcing
How did you find your way into your role?
Latest news from Datamonitor
October 28, 2008Sales and Marketing
Targeted therapy cancer brands to achieve sales of over $42 billion by 2017Targeted therapies have improved treatment outcomes in cancer …
Novartis appoints Reinhardt as chief operating officer
October 24, 2008Sales and Marketing Novartis
Novartis has shaken up its senior management structure with the creation of a new post – chief operating officer. From …
Merck to streamline management structure
October 24, 2008Sales and Marketing Merck
Merck has announced a new round of job cuts and restructuring in a bid to update its business model and …
Roche dips on Tamiflu decline
October 24, 2008Sales and Marketing Roche
Roche's sales dropped 2% to 33.3 billion Swiss francs in the first nine months of 2008, due to a sharp …
Leaders use war gaming to strengthen UK biotech
October 22, 2008Research and Development, Sales and Marketing biotech
Bioscience leaders from both sides of the Atlantic have joined in a war game that could help boost the UK …
PPRS talks stall
October 22, 2008Sales and Marketing par
Talks on the future of pharmaceutical pricing scheme the PPRS have stumbled into trouble, after it emerged a major part …
Key expert-pharma relations: a new era
October 20, 2008Medical Communications, Sales and Marketing industry relations, key opinion leaders, pharma
The relationship between doctors and the pharmaceutical industry has attracted considerable criticism in the past five years. Scepticism has risen, …
Latest news from Datamonitor
October 20, 2008Sales and Marketing
Opportunity knocks for big pharmaceutical companies in the credit crunchAlthough the credit crunch has left non-financial services companies, including those …
Pfizer repackages range for safety
October 17, 2008Manufacturing and Production packaging
Pfizer is repackaging its medicines in a bid to make dosing instructions clearer. The National Patient Safety Agency (NPSA) estimates …
NHS improving but London lags behind
October 17, 2008NHS
The Healthcare Commission's third yearly snapshot of the NHS in England shows a significant increase in trusts performing well, but …
MedImmune opens new R&D facility in Cambridge
October 17, 2008Research and Development Cambridge, MedImmune
MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …
Companies try to quell rumours on prasugrel
October 17, 2008Sales and Marketing Efient, lilly
Daiichi-Sankyo and Lilly have responded to media speculation around the FDA's make-or-break ruling on their major new drug prasugrel. The …
Government looks to plug health research gaps
October 16, 2008Research and Development
The government is investing £5 million in specialist research projects on the planning and provision of health services. The new …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
